Quantoom is your full stack RNA partner
Our platform enables anyone to unlock RNA's potential.
Partner
Your diseaseYour antigenYour sequenceOne platform. Three pillars.
1
Design
2
Produce
3
Deliver
Partner
Your RNA candidateOur N-Force platform unifies design, production and delivery into one workflow, so partners move from a sequence/disease to a candidate faster, cheaper, and with freedom to operate built in from day one.
Making RNA therapies affordable, scalable, and accessible worldwide, from mass pandemic response to personalized cancer treatment, with the world's only unified, end-to-end RNA platform.
The N-Force toolbox
Design. Produce. Deliver.
End-to-end RNA platform, based on three integrated components, covering the full value chain to accelerate RNA development & manufacturing.
Why Quantoom?
What it means for you
Five levers of the N-Force platform. Hover or tap a lever to see how it changes the economics of an RNA program.
−18 months
cut from process development
Turnkey workflows drastically reducing the development timeline per program.
€1
COGS on 20M pandemic campaigns
- PCT: personalized treatments viable at a fraction of today's cost
- Pandemic: COGS as low as €1 for 20M pandemic campaigns
- Animal Health: COGS as low as ~€2 per 1,000 doses in saRNA-based vaccine
Micro → Midi Flex
same process, more units
Add Micro / Mini / Midi Flex units to grow volume - never re-develop the process.
Any construct
one process, every program
One process, any RNA construct - zero re-development between programs. The same platform for all your programs.
CNP
freedom to operate, built in
Our Calixarene Nanoparticle (CNP) is a proprietary class of lipid-like delivery molecules engineered for efficient RNA encapsulation, cellular uptake and endosomal escape and RNA release - while reducing dependence on heavily patented ionizable lipid families.
Track record
Proven across pre-clinical and target-species evaluation
The N-Force platform has been evaluated across multiple in vivo studies and provides preclinical evidence.
Versatility acrossmodalities and applications
Exploratory tolerability(pre-GLP)
28RNA production systems sold worldwide
45+clients
27countries
Ready to reinvent your RNA program?
Talk to our team about how the N-Force toolbox can compress your timelines from sequence to dose.
Book a call →